Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.

A reliable, selective and sensitive stability-indicating RP-HPLC assay was established for the quantitation of bromazepam (BMZ) and one of the degradant and stated potential impurities; 2-(2-amino-5-bromobenzoyl) pyridine (ABP). The assay was accomplished on a C18 column (250 mm × 4.6 mm i.d., 5 μm...

Full description

Bibliographic Details
Main Authors: Hany W Darwish, Nesma A Ali, Ibrahim A Naguib, Mohamed R El Ghobashy, Abdullah M Al-Hossaini, Maha M Abdelrahman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0244951
_version_ 1818743203202859008
author Hany W Darwish
Nesma A Ali
Ibrahim A Naguib
Mohamed R El Ghobashy
Abdullah M Al-Hossaini
Maha M Abdelrahman
author_facet Hany W Darwish
Nesma A Ali
Ibrahim A Naguib
Mohamed R El Ghobashy
Abdullah M Al-Hossaini
Maha M Abdelrahman
author_sort Hany W Darwish
collection DOAJ
description A reliable, selective and sensitive stability-indicating RP-HPLC assay was established for the quantitation of bromazepam (BMZ) and one of the degradant and stated potential impurities; 2-(2-amino-5-bromobenzoyl) pyridine (ABP). The assay was accomplished on a C18 column (250 mm × 4.6 mm i.d., 5 μm particle size), and utilizing methanol-water (70: 30, v/v) as the mobile phase, at a flow rate of 1.0 ml min-1. HPLC detection of elute was obtained by a photodiode array detector (DAD) which was set at 230 nm. ICH guidelines were adhered for validation of proposed method regarding specificity, sensitivity, precision, linearity, accuracy, system suitability and robustness. Calibration curves of BMZ and ABP were created in the range of 1-16 μg mL-1 with mean recovery percentage of 100.02 ± 1.245 and 99.74 ± 1.124, and detection limit of 0.20 μg mL-1 and 0.24 μg mL-1 respectively. BMZ stability was inspected under various ICH forced degradation conditions and it was found to be easily degraded in acidic and alkaline conditions. The results revealed the suitability of the described methodology for the quantitation of the impurity (ABP) in a BMZ pure sample. The determination of BMZ in pharmaceutical dosage forms was conducted with the described method and showed mean percentage recovery of 99.39 ± 1.401 and 98.72 ± 1.795 (n = 6), respectively. When comparing the described procedure to a reference HPLC method statistically, no significant differences between the two methods in regard to both accuracy and precision were found.
first_indexed 2024-12-18T02:24:41Z
format Article
id doaj.art-cbcf7f934f284aeeba881ac37a4231c8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-18T02:24:41Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cbcf7f934f284aeeba881ac37a4231c82022-12-21T21:24:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01163e024495110.1371/journal.pone.0244951Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.Hany W DarwishNesma A AliIbrahim A NaguibMohamed R El GhobashyAbdullah M Al-HossainiMaha M AbdelrahmanA reliable, selective and sensitive stability-indicating RP-HPLC assay was established for the quantitation of bromazepam (BMZ) and one of the degradant and stated potential impurities; 2-(2-amino-5-bromobenzoyl) pyridine (ABP). The assay was accomplished on a C18 column (250 mm × 4.6 mm i.d., 5 μm particle size), and utilizing methanol-water (70: 30, v/v) as the mobile phase, at a flow rate of 1.0 ml min-1. HPLC detection of elute was obtained by a photodiode array detector (DAD) which was set at 230 nm. ICH guidelines were adhered for validation of proposed method regarding specificity, sensitivity, precision, linearity, accuracy, system suitability and robustness. Calibration curves of BMZ and ABP were created in the range of 1-16 μg mL-1 with mean recovery percentage of 100.02 ± 1.245 and 99.74 ± 1.124, and detection limit of 0.20 μg mL-1 and 0.24 μg mL-1 respectively. BMZ stability was inspected under various ICH forced degradation conditions and it was found to be easily degraded in acidic and alkaline conditions. The results revealed the suitability of the described methodology for the quantitation of the impurity (ABP) in a BMZ pure sample. The determination of BMZ in pharmaceutical dosage forms was conducted with the described method and showed mean percentage recovery of 99.39 ± 1.401 and 98.72 ± 1.795 (n = 6), respectively. When comparing the described procedure to a reference HPLC method statistically, no significant differences between the two methods in regard to both accuracy and precision were found.https://doi.org/10.1371/journal.pone.0244951
spellingShingle Hany W Darwish
Nesma A Ali
Ibrahim A Naguib
Mohamed R El Ghobashy
Abdullah M Al-Hossaini
Maha M Abdelrahman
Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.
PLoS ONE
title Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.
title_full Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.
title_fullStr Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.
title_full_unstemmed Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.
title_short Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam.
title_sort development and validation of a stability indicating rp hplc dad method for the determination of bromazepam
url https://doi.org/10.1371/journal.pone.0244951
work_keys_str_mv AT hanywdarwish developmentandvalidationofastabilityindicatingrphplcdadmethodforthedeterminationofbromazepam
AT nesmaaali developmentandvalidationofastabilityindicatingrphplcdadmethodforthedeterminationofbromazepam
AT ibrahimanaguib developmentandvalidationofastabilityindicatingrphplcdadmethodforthedeterminationofbromazepam
AT mohamedrelghobashy developmentandvalidationofastabilityindicatingrphplcdadmethodforthedeterminationofbromazepam
AT abdullahmalhossaini developmentandvalidationofastabilityindicatingrphplcdadmethodforthedeterminationofbromazepam
AT mahamabdelrahman developmentandvalidationofastabilityindicatingrphplcdadmethodforthedeterminationofbromazepam